Inhibition of Pathogen Adhesion by Bacterial Outer Membrane‐Coated Nanoparticles

Anti‐adhesion therapies interfere with the bacterial adhesion to the host and thus avoid direct disruption of bacterial cycles for killing, which may alleviate resistance development. Herein, an anti‐adhesion nanomedicine platform is made by wrapping synthetic polymeric cores with bacterial outer me...

Full description

Saved in:
Bibliographic Details
Published in:Angewandte Chemie International Edition 2019-08, Vol.58 (33), p.11404-11408
Main Authors: Zhang, Yue, Chen, Yijie, Lo, Christopher, Zhuang, Jia, Angsantikul, Pavimol, Zhang, Qiangzhe, Wei, Xiaoli, Zhou, Zhidong, Obonyo, Marygorret, Fang, Ronnie H., Gao, Weiwei, Zhang, Liangfang
Format: Article
Language:English
Subjects:
Adhesins
Adhesion
anti-adhesion
Bacteria
bacterial membranes
biomimetic nanoparticles
Disruption
Epithelial cells
Fabrication
Helicobacter pylori
infectious diseases
Membranes
Mimicry
nanomedicine
Nanoparticles
Nanotechnology
Outer membranes
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Anti‐adhesion therapies interfere with the bacterial adhesion to the host and thus avoid direct disruption of bacterial cycles for killing, which may alleviate resistance development. Herein, an anti‐adhesion nanomedicine platform is made by wrapping synthetic polymeric cores with bacterial outer membranes. The resulting bacterium‐mimicking nanoparticles (denoted “OM‐NPs”) compete with source bacteria for binding to the host. The “top‐down” fabrication of OM‐NPs avoids the identification of the adhesins and bypasses the design of agonists targeting these adhesins. In this study, OM‐NPs are made with the membrane of Helicobacter pylori and shown to bind with gastric epithelial cells (AGS cells). Treatment of AGS cells with OM‐NPs reduces H. pylori adhesion and such anti‐adhesion efficacy is dependent on OM‐NP concentration and its dosing sequence. Nanoparticles coated with bacterial outer membranes (denoted “OM‐NPs”) are reported as an anti‐adhesion nanomedicine that competes with source bacteria for binding sites and therefore inhibits bacterial adhesion to the host cells. Specifically, OM‐NPs prepared with Helicobacter pylori outer membrane were demonstrated to inhibit bacterial binding to the gastric epithelial cells and stomach tissues.
ISSN:1433-7851
1521-3773
DOI:10.1002/anie.201906280